Barbara Pasculli

6PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Cancer diagnosisPredictive and prognostic markersMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 27, 2026
Early Immune Signature Features, Including TLR2 and TLR4 Expression, Are Associated with Complete Remission After CD19 CAR-T Cell Therapy.

|Dec 08, 2025
Comprehensive Molecular Screening by Next Generation Sequencing of Gastrointestinal Stromal Tumors (GISTs): In Silico Analysis and Classification of Rare KIT Exon 11 Mutations.

Maria Grazia Rodriquenz, Barbara Pasculli, Michelina Rendina

|Sep 13, 2025
KRAS Mutations in Colorectal Adenocarcinoma: Incidence and Association with Histological Features with Particular Reference to Gly12Asp in a Multicenter GIPAD Real-World Study.

Paola Parente, Valentina Angerilli, Federica Grillo

|Nov 27, 2024
Tumor Suppressor miR-27a-5p and Its Significance for Breast Cancer.

Paola Parrella, Raffaela Barbano, Katharina Jonas

|Oct 19, 2019
Hsa-miR-210-3p expression in breast cancer and its putative association with worse outcome in patients treated with Docetaxel.

Barbara Pasculli, Raffaela Barbano, Michelina Rendina

|Jun 20, 2019
Can Epigenetics of Endothelial Dysfunction Represent the Key to Precision Medicine in Type 2 Diabetes Mellitus?

Celeste Coco, Luca Sgarra, Maria Assunta Potenza

Pageof 1

Frequent Collaborators

6 joint publications

Paola Parrella

2 joint publications

Andrea Fontana

2 joint publications

Paolo Graziano

1 joint publications

Celeste Coco